Redux is supported by a world-class group of advisors with decades of experience in bringing bio-based and animal health solutions to market.
Collectively, the team holds deep expertise in the areas of animal health and aquaculture, vaccines, regulatory affairs, industrial biotech, scale up, and product development.
Lincoln Tubbs is an experienced Animal Health professional with a demonstrated history of leading innovation “firsts” in the pharmaceuticals industry, including licensure of the first DNA vaccine for Europe via centralized procedure. He has led teams through the early discovery, development, and tech transfer of innovative vaccines for aquaculture, building a pipeline of safe and effective biological solutions. Lincoln is uniquely skilled in international business operations, biologics product development, licensure and regulatory affairs, and global launches of aqua, poultry, swine & cattle products. He holds a PhD in Applied Pharmacokinetics & Pharmacodynamics from the University of Auckland. As the Chief Executive Officer of Redux Bio, Lincoln brings decades of experience bringing novel animal health products to market.
Tony Day is a seasoned biotechnology executive, with over 30 years of experience and leadership roles in both R&D and Business Development. He was the 6th employee at Solazyme, joining in 2006 as Head of R&D, and later VP of Commercialization where he led many of Solazyme’s seminal early partnership deals (JVs and JDAs). He has experience in scale up and regulatory approval of algal derived products, including novel food ingredients. Tony is a chemist and enzymologist by training and received his PhD from Imperial College London. He studied under Professor Sir Alan Fersht FRS for his postdoctoral at the University of Cambridge. Tony is also the recipient of the Presidential Green Chemistry Award in 2014.
After completing his thesis in bioengineering of enzymes for the production of specialty chemicals at the University of Oxford, Rich spend the early part of his career in investment banking in London funding early stage companies. He moved to California in 2009 to study his MBA at UC Berkeley Haas School of Business. Joining Solazyme in 2011, Rich established Solazyme’s business analytics department responsible for market analysis, strategy, and deal structuring for all of Solazyme’s business development activities. He was also the Product Line Director for Solazyme’s highly successful omega-3 product, AlgaPrime DHA. Rich has decades of experience in industrial biotechnology, and also runs a consulting firm focused on the scale up of biotech and foodtech startups.
Bert Soenen holds 35+ years of experience in regulatory affairs of feed additives, vaccines, and veterinary pharmaceutical products. Previously the Senior Director of Regulatory Affairs at global multinationals, Bert brings an in-depth understanding of the registration of innovative products (including feed additives), GMP certifications, and the global regulatory landscape to the Redux Team. He studied at University of Ghent in Belgium for Animal Science.
Ian Thompson is a veterinary vaccine leader with 20+ years of experience in the field. As the Global Head of Vaccines and Biologics for several global multinational companies, Ian brings expertise in leading global teams in all aspects of vaccine development and deployment. He holds a PhD from University of Aberdeen.
Loc Tran has 15+ years in the animal health industry working with fish vaccine development, disease diagnostics, therapeutics development, aquaculture product testing, and new innovations in aquaculture. He is also an active professor of Aquaculture Pathology. Loc holds a PhD in shrimp pathology and aquaculture from University of Arizona.
Aaron Schacht is a global leader in product development and commercialization with over 30 years in the field of life science innovation. As an established executive, he brings deep experience in pharma, medicinal chemistry, veterinary medicine, vaccine development, M&A, and business development. He holds a degree in chemistry from University of Illinois at Urbana-Champaign.
John (JJ) Johnstone
JJ is a world-class fermentation engineer with 3 decades of process development and scale up experience. He has built and run manufacturing plants globally in his Senior Manufacturing roles at some of the largest industrial biotechnology players. JJ holds a chemical engineering degree from University of Glasgow.
Spencer Russell is a specialist in fish health with over 25 years in the industry. He brings expertise in aquatic vaccine research, autogenous vaccine production, and is a current professor of Fish Health at Vancouver Island University. He holds a PhD and a DVM from University of Guelph.
Miguel Angelo De Facci de Oliveira
Miguel Angelo De Facci de Oliveira is a seasoned executive with 36+ years in the global food&feed markets. He brings a range of experience in engineering, industrial operations, international business development, and JV formation. Miguel has held the roles of COO and VP of Innovation at several prominent players in industrial biotech. He holds a degree in chemical engineering from UFRGS and a PhD in Food Engineering from Norwegian University of Science and Technology.